Keywords: onyx, drops, lead, drug, cuts, workforce, halted

Onyx drops lead drug and cuts workforce

Article | 03 February 2003

Print This

Onyx has halted the clinical development of ONYX-015 for head and neckcancer and will cut its workforce by 25%, refocusing its ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in